Lantern Pharma Inc. - Common Stock (LTRN)

Lantern Pharma Inc is a biotechnology company focused on leveraging artificial intelligence and machine learning to accelerate the drug discovery and development process, particularly for oncology therapeutics

The company aims to identify and develop personalized treatment options that target specific patient populations based on their genetic profiles and responses to various therapies. By harnessing advanced technologies, Lantern Pharma seeks to streamline clinical trials and bring innovative cancer treatments to market more efficiently, ultimately improving patient outcomes and advancing the field of precision medicine.